Boardroom Alpha
Boardroom Alpha
NATR · Current Report (Form 8-K) · Filed May 7, 2026

Natures Sunshine Products Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 7, 2026
Period
May 7, 2026
Ticker
NATR
Accession
0001628280-26-032330
Boardroom Alpha · Filing insights

Shareholders approved the 2026 Stock Incentive Plan, authorizing up to 1,500,000 shares, at the May 6, 2026 annual meeting.

About Natures Sunshine Products Inc
Market cap
$367M
1Y TSR
+56.1%
3Y TSR
+22.0%
Board grade
A-
Sector
Consumer Defensive
CEO
Kenneth G Romanzi
Last annual meeting: May 6, 2026 · View full Natures Sunshine Products Inc profile →
natr-20260507

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 7, 2026

 NS-logo-darkgreen.jpg
NATURE’S SUNSHINE PRODUCTS, INC.
(Exact name of registrant specified in its charter)
 
Utah 001-34483 87-0327982
(State or other jurisdiction of
incorporation)
 (Commission File Number) (I.R.S. Employer Identification No.)
 2901 West Bluegrass Blvd., Suite 100
Lehi, Utah 84043
(Address of principal executive offices and zip code)

Registrant’s telephone, including area code:  (801) 341-7900

N/A
(Former name and former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each ClassTrading SymbolName of each exchange on which registered
Common Stock, no par valueNATRNasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02    Results of Operations and Financial Condition.
 
On May 7, 2026, Nature’s Sunshine Products, Inc. (the “Company”) issued a press release announcing financial results for the first quarter ended March 31, 2026. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.

The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assists management and investors in evaluating and comparing period-to-period results in a more meaningful and consistent manner. A reconciliation of GAAP to non-GAAP results is provided in the press release.


Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 6, 2026, Nature’s Sunshine Products, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”) and the shareholders of the Company approved the adoption of the 2026 Stock Incentive Plan (the “Plan”). With shareholder approval obtained, the Plan is effective as of May 6, 2026. Subject to adjustment in certain circumstances, the Plan authorizes up to 1,500,000 shares of common stock to be reserved for issuance.

Any employee, officer, consultant, independent contractor, advisor or non-employee director providing services to the Company or any Affiliate whom the Committee determines to be an Eligible Person is eligible to receive an award under the Plan. Generally, grants may be made in any of the following forms: Stock Options, Stock Appreciation Rights, Restricted Stock and Restricted Stock-Units, Performance Awards, Dividend Equivalents, Stock Awards, and Other Stock-Based Awards.

A summary of the Plan appears on pages 46 to 52 of the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 27, 2026 (the “Proxy Statement”) and is incorporated by reference herein. The foregoing description of the Plan and the summary included in the Company’s Proxy Statement is qualified in their entirety by reference to the full text of the Plan, which is filed as Exhibit 10.1 and is incorporated by reference herein.


Item 5.07    Submission of Matters to a Vote of Security Holders
 
The Company held its Annual Meeting of Shareholders on May 6, 2026 (the "Annual Meeting"). The proposals voted upon at the Annual Meeting and the final results of the shareholder vote on each proposal are set forth below. Each of the proposals is described in greater detail in the Company’s Proxy Statement.
 
(1)         Election of Directors. The Company’s shareholders elected all persons nominated for election as directors as set forth in the Proxy Statement to serve until the next Annual Meeting of Shareholders. The following table sets forth the vote of the shareholders at the Annual Meeting with respect to the election of directors: 




NomineeForWithheldBroker Non-Vote
Steven Fasching13,775,074156,2401,286,995
Curtis Kopf13,735,217196,0971,286,995
Katie May13,788,255143,0591,286,995
Tess Roering13,804,049127,2651,286,995
Kenneth Romanzi13,806,920124,3941,286,995
Robert Straus13,749,307182,0071,286,995
Heidi Wissmiller13,745,460185,8541,286,995
Rong Yang13,784,698146,6161,286,995
 


(2)         Advisory Resolution on Executive Officer Compensation. The Company’s shareholders, on an advisory basis, voted to approve an advisory resolution to approve the compensation of the Company’s named executive officers as follows:

For AgainstAbstainBroker Non-Votes
11,288,205779,0561,864,0531,286,995


(3)         Ratification of Appointment of Independent Registered Public Accounting Firm. The Company’s shareholders voted upon and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The following table sets forth the vote of the shareholders at the Annual Meeting with respect to the ratification of Deloitte & Touche LLP: 

 
ForAgainstAbstain
14,619,306566,27432,729


There were no broker non-votes in the ratification of appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

(4)    Approval of 2026 Stock Incentive Plan. The Company’s shareholders voted upon and ratified the 2026 Stock Incentive Plan. The following table sets forth the votes of the shareholders at the Annual Meeting with respect to the 2026 Stock Incentive Plan.

For AgainstAbstainBroker Non-Votes
6,357,2455,723,1071,850,9621,286,995


Item 9.01    Financial Statements and Exhibits
Item No. Exhibit
10.1
99.1 
104Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 NATURE’S SUNSHINE PRODUCTS, INC.
   
Dated: May 7, 2026By:/s/ Nathan G. Brower
  Nathan G. Brower, Executive Vice President, General Counsel and Corporate Secretary

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Natures Sunshine Products Inc (NATR)

Reference

Frequently asked questions

When did Natures Sunshine Products Inc file this 8-K?
Natures Sunshine Products Inc (NATR) filed this Current Report (Form 8-K) with the SEC on May 7, 2026. The accession number assigned by EDGAR is 0001628280-26-032330.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved the 2026 Stock Incentive Plan, authorizing up to 1,500,000 shares, at the May 6, 2026 annual meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Natures Sunshine Products Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Natures Sunshine Products Inc has filed under CIK 275053, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer